All lobbying filings

THE MCMANUS GROUP

THE MCMANUS GROUP filed a Q4 report for INFUSION PROVIDERS ALLIANCE on January 20, 2026, reporting $90,000 in lobbying income.

Lobbying for INFUSION PROVIDERS ALLIANCE · Association representing infusion drug providers.

All filings by THE MCMANUS GROUP · Everything INFUSION PROVIDERS ALLIANCE has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$90,000

What the client paid this registrant for the period.

Client based in

Delaware

Official filing document

Lobbyists on this filing 1

JOHN MCMANUS

Previously held: Staff Director, W&M Health Subcommittee. LA, Rep. Bill Thomas.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Advocating for access to and reimbursement for biosimilars.

Medicare/Medicaid

Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to virtual supervision of infusion drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F)

Bills named in this filing 1

H.R. 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.